Note: Ingredients listed on restricted chemical lists
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
1-<4
EC/CAS
25322-68-3
Name of the chemical
polyethyleneglycol
Concentration
0.5-<2
EC/CAS
9003-39-8
Name of the chemical
polyvinylpyrrolidone
Concentration
2.8
General Information
Revision date
2022-05-25
Product name
VALTREX CAPLETS
Product Synonyms
VALTREX FILM-COATED CAPSULE-SHAPED TABLETS * VALTREX CAPLETS 500 MG *
Emergency telephone
VERISK 3E GLOBAL INCIDENT RESPONSE
Icons in SDS
Company Information
company name
GlaxoSmithKline Canada
e-mail address of the competent person responsible for the Safety Data Sheet
msds@gsk.com
GHS Information
Signal word
Warning
Section 2
Physical hazards
Not classified.
Health hazards
Acute toxicity, oral Category 4
Environmental hazards
Not classified.
Signal word
Warning
Hazard statements
Harmful if swallowed.
Prevention
Wash thoroughly after handling. Do not eat, drink or smoke when using this product.
Response
IF SWALLOWED: Call a POISON CENTRE/doctor/ if you feel unwell. Rinse mouth.
Storage
Not available.
Disposal
Dispose of contents/container in accordance with local/regional/national/international regulations.
Additional information
12.6 % of the mixture consists of component(s) of unknown acute oral toxicity. 93.4 % of the mixture consists of component(s) of unknown acute dermal toxicity. 93.4 % of the mixture consists of component(s) of unknown acute inhalation toxicity. 87 % of the mixture consists of component(s) of unknown acute hazards to the aquatic environment. 87 % of the mixture consists of component(s) of unknown long-term hazards to the aquatic environment.
2.3 Other hazards
Caution - Pharmaceutical agent. See section 11 of the SDS for additional information on health hazards.
